GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 105 filers reported holding GENMARK DIAGNOSTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,487,000 | -18.0% | 410,483 | -12.1% | 0.01% | -11.1% |
| Q2 2019 | $3,032,000 | -8.4% | 467,118 | +0.0% | 0.01% | -10.0% |
| Q1 2019 | $3,311,000 | +46.0% | 466,949 | +0.0% | 0.01% | +25.0% |
| Q4 2018 | $2,268,000 | -42.4% | 466,737 | -12.8% | 0.01% | -33.3% |
| Q3 2018 | $3,936,000 | +2.8% | 535,466 | -10.8% | 0.01% | 0.0% |
| Q2 2018 | $3,828,000 | +17.9% | 600,009 | +0.5% | 0.01% | +9.1% |
| Q1 2018 | $3,246,000 | +32.2% | 596,762 | +1.3% | 0.01% | +37.5% |
| Q4 2017 | $2,456,000 | -56.7% | 588,970 | 0.0% | 0.01% | -60.0% |
| Q3 2017 | $5,672,000 | -9.0% | 588,970 | +11.8% | 0.02% | -23.1% |
| Q2 2017 | $6,232,000 | +52.4% | 526,860 | +65.2% | 0.03% | +44.4% |
| Q1 2017 | $4,088,000 | +12.2% | 318,860 | +7.1% | 0.02% | +12.5% |
| Q4 2016 | $3,644,000 | – | 297,650 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versor Investments LP | 2,664,831 | $63,689,000 | 3.80% |
| Chicago Capital Management, LLC | 318,113 | $7,603,000 | 3.54% |
| First Trust Capital Management L.P. | 564,758 | $13,498,000 | 2.64% |
| WATER ISLAND CAPITAL LLC | 1,693,162 | $40,467,000 | 2.47% |
| Sand Grove Capital Management LLP | 992,068 | $23,710,000 | 2.31% |
| EMC Capital Management | 121,023 | $2,892,000 | 2.06% |
| OMNI PARTNERS LLP | 1,540,671 | $36,822,000 | 1.82% |
| TIG Advisors, LLC | 1,774,849 | $42,419,000 | 1.60% |
| Cowen Prime Services LLC | 174,850 | $4,179,000 | 1.58% |
| G2 Investment Partners Management LLC | 396,400 | $9,474,000 | 1.50% |